$1.02
0.033.03%
Pre-Market: 5:59 PM EDT
15 minutes delayed
NeuroOne Medical Tech
NMTCNASDAQ
NeuroOne Medical Tech (NASDAQ:NMTC) Stock, Analyst Ratings, Price Targets, Forecasts
NeuroOne Medical Technologies Corp has a consensus price target of $3.98 based on the ratings of 3 analysts. The high is $5.75 issued by Alliance Global Partners on December 3, 2021. The low is $2.2 issued by Alliance Global Partners on August 15, 2023. The 3 most-recent analyst ratings were released by Alliance Global Partners, Alliance Global Partners, and Craig-Hallum on August 15, 2023, December 3, 2021, and November 15, 2021, respectively. With an average price target of $4.65 between Alliance Global Partners, Alliance Global Partners, and Craig-Hallum, there's an implied 355.88% upside for NeuroOne Medical Technologies Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Alliance Global Partners
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for NeuroOne Medical Tech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 08/15/2023 | Buy Now | 115.69% | Alliance Global Partners | Ben Haynor | $3.25 → $2.2 | Maintains | Buy | Get Alert |
| 03/28/2022 | Buy Now | — | Craig-Hallum | Alexander Nowak | — | Downgrade | Buy → Hold | Get Alert |
| 12/03/2021 | Buy Now | 463.73% | Alliance Global Partners | — | — | Initiates | → Buy | Get Alert |
| 11/15/2021 | Buy Now | 488.24% | Craig-Hallum | Alexander Nowak | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for NeuroOne Medical Tech (NMTC) stock?
The latest price target for NeuroOne Medical Tech (NASDAQ:NMTC) was reported by Alliance Global Partners on August 15, 2023. The analyst firm set a price target for $2.20 expecting NMTC to rise to within 12 months (a possible 115.69% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NeuroOne Medical Tech (NMTC)?
The latest analyst rating for NeuroOne Medical Tech (NASDAQ:NMTC) was provided by Alliance Global Partners, and NeuroOne Medical Tech maintained their buy rating.
When was the last upgrade for NeuroOne Medical Tech (NMTC)?
There is no last upgrade for NeuroOne Medical Tech
When was the last downgrade for NeuroOne Medical Tech (NMTC)?
The last downgrade for NeuroOne Medical Technologies Corp happened on March 28, 2022 when Craig-Hallum changed their price target from N/A to N/A for NeuroOne Medical Technologies Corp.
When is the next analyst rating going to be posted or updated for NeuroOne Medical Tech (NMTC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroOne Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroOne Medical Tech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating NeuroOne Medical Tech (NMTC) correct?
While ratings are subjective and will change, the latest NeuroOne Medical Tech (NMTC) rating was a maintained with a price target of $3.25 to $2.20. The current price NeuroOne Medical Tech (NMTC) is trading at is $1.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.